Hudson Technologies Inc /NyHDSN

Hudson Technologies now carries $130.7 million of refrigerant inventory on its balance sheet, a stockpile that could cushion supply shocks or tie up cash if demand unexpectedly softens. The company’s most recent 10-Q for the quarter ending 31 March 2026 shows net cash used in operating activities of $12.8 million, a working-capital haemorrhage that would make even the most sanguine treasurer reach for the ammonia spill kit. Net income attributable to shareholders clocked in at $330,000, which works out to $0.01 per diluted share across 42.6 million shares. Operating income was $1.5 million, a figure that sounds less like a growth engine and more like a firm keeping the lights on while it waits for the refrigerant cycle to turn. (source: Hudson Technologies 10-Q for the quarter ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/925528/000092189526001775/xslF345X06/form414670002_07082026.xml)

Hudson’s core business is on-site refrigerant services: recovery, reclamation, system conversions, and chiller performance optimisation across the United States. Its nationwide network of service facilities deploys proprietary gear like the ZugiBeast® to extract refrigerants from systems large and small, whether the job is routine maintenance or an emergency call-out after a compressor seizure. The product rail boils down to three offerings: refrigerant recovery and system conversions, on-site services to revive chiller efficiency, and a portfolio of reclaimed refrigerants for customers who want to avoid virgin supply constraints. The company’s rhetoric leans hard on “sustainable best practices” and “next-generation technologies,” but the evidence reads like a mature industrial with thin margins and a balance sheet that prefers cash to buzzwords. (source: Hudson Technologies product pages, https://www.hudsontech.com/refrigerants/our-products/, https://www.hudsontech.com/on-site-refrigerant-services/, https://www.hudsontech.com/on-site-refrigerant-services/refrigerant-recovery/)

On 22 July 2026, the company filed Form 4 insider trades, followed on 14 July by an amended Schedule 13G/A showing a new 5% passive holder, and on 8 July by another Form 4. The filings cluster reads like a season finale of corporate disclosure theatre: everyone’s either repositioning, disclosing, or reminding the market that they exist. The Schedule 13G/A update is particularly polite corporate language for “here comes a new shareholder who arrived via the kindness of the filing system rather than the kindness of strangers.” The SEC filings index confirms the deluge, with multiple Forms 4, 3, and 13G/A landing in July alone, a pace that would make even the busiest activist blush. (source: SEC EDGAR filings index and submissions JSON, https://www.sec.gov/edgar/browse/?CIK=925528, https://data.sec.gov/submissions/CIK0000925528.json)

The company’s latest narrative push is a preliminary agreement with Icorium to commercialise a novel extractive distillation technology aimed at single-stream refrigerant reclamation. The press release frames the deal as a critical path to bolstering capacity ahead of anticipated demand increases under the AIM Act and looming reductions in virgin refrigerant supply. Translation: if the regulators and the physics of supply align, Hudson could have a new tool in the toolbox. Until then, it’s an early-stage handshake with no contracted volumes, no revenue visibility, and a press release photograph that looks suspiciously like stock imagery. The company’s own product pages still list legacy refrigerants and standard services, not the promised technology leap, so the market is being asked to price a future that hasn’t arrived. (source: Hudson Technologies press release, https://www.hudsontech.com/company-news-and-financial-results/hudson-technologies-and-icorium-reach-preliminary-agreement-to-establish-a-commercialization-partnership-for-novel-extractive-distillation-technology/)

There is no revenue, profit, or cash-flow disclosure for the extractive distillation programme in the latest filings, so investors are left to guess whether this is a strategic pivot or a slide-deck story waiting for a pilot plant. The core business-refrigerant recovery, system conversions, and on-site services-remains the only operating segment with disclosed financials, and those numbers are modest by any measure. The company’s assets of $308.9 million are anchored by $130.7 million of inventory and $19.4 million of cash, while liabilities of $71.2 million leave shareholders with $237.7 million of equity. The firm spent $1.1 million on capex in the quarter and generated negative operating cash flow of $12.8 million, a working-capital draw that will matter more than the next vapourware press release. (source: Hudson Technologies 10-Q for the quarter ended 2026-03-31, https://www.sec.gov/Archives/edgar/data/925528/000092189526001775/xslF345X06/form414670002_07082026.xml)

For a deeper read, keep an eye on two things: first, whether Hudson can convert the Icorium preliminary agreement into contracted volumes or a pilot programme with measurable cash receipts; second, whether the operating cash burn continues or reverses as the refrigerant cycle tightens. The filing rail has not supplied segment-level guidance, EPS ranges, or dividend commentary, so the market is flying blind on the only metrics that count. Until then, the stock is pricing a story that the balance sheet hasn’t yet collected. (source: SEC company facts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0000925528.json)